Article

Niksch selected as industry representative on FDA panel

Irvine, CA-Barbara A. Niksch, MBA, has accepted an appointment from the U.S. Department of Health and Human Services to serve as industry representative on the FDA's Ophthalmic Devices Panel of the Medical Devices Advisory Committee. Niksch is vice president of regulatory, quality, and clinical affairs, Visiogen Inc.

Selected by a committee of her peers in the medical device industry for her experience and leadership, Niksch will contribute to the panel by providing balanced recommendations based on her industry knowledge. As an industry representative, she will act on behalf of regulated industry at committee meetings. Niksch will present issues from the perspective of the affected industry and not as an individual from a specific sponsor.

The panel consists of seven voting members with specific expertise in ophthalmology and two non-voting members (the industry representative and the consumer representative).

Related Videos
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.